If IP-10/CXCR3 restricts ZIKV infection in other urogenital tract tissues and the mechanism of action is identified, IP-10/CXCR3 signaling could serve as a potential therapeutic target to ultimately interrupt sexually-transmitted ZIKV infections. This evidence concerns the gene CXCL10 and Zika virus infectious disease.